Rebecca Haberman1, Lourdes M Perez-Chada2, Joseph F Merola3, Jose Scher1, Alexis Ogdie4, Soumya M Reddy5. 1. Department of Medicine, Division of Rheumatology, New York University Langone Health, New York, NY, USA. 2. Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. 3. Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 4. Department of Medicine/Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 5. Department of Medicine, Division of Rheumatology, New York University Langone Health, New York, NY, USA. Soumya.Reddy@nyumc.org.
Abstract
PURPOSE OF REVIEW: Despite a robust therapeutic landscape, significant gaps exist in the quality of care of psoriatic disease. Thus, an improved understanding of the challenges in providing quality care and the implementation of effective strategies to overcome them is needed. In this review, we summarize the burden of psoriatic disease, discuss the challenges in the care of psoriatic patients, and outline how combined dermatology-rheumatology clinics bridge many of these gaps. RECENT FINDINGS: Multiple challenges are faced in providing high-quality care to patients with psoriasis and psoriatic arthritis from the pre-diagnosis phase of disease to the follow-up period. Challenges are mainly driven by lack of education of patients and healthcare providers, inefficient communication between specialists, lack of a holistic approach to patients, and limitations of available therapies. The Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) is working on demonstrating the effectiveness of combined dermatology-rheumatology clinics in addressing some of these challenges. Recent findings show that combined clinic models may improve quality of care by raising awareness of psoriatic disease, fostering educational activities for both patients and physicians, and allowing for comprehensive evaluation and management of patients through improved communications between disciplines. Psoriasis and psoriatic arthritis are complex diseases that often require an interdisciplinary approach. Thus, combined dermatology-rheumatology clinics and local-regional partnerships are potentially effective in improving quality of care in psoriatic disease.
PURPOSE OF REVIEW: Despite a robust therapeutic landscape, significant gaps exist in the quality of care of psoriatic disease. Thus, an improved understanding of the challenges in providing quality care and the implementation of effective strategies to overcome them is needed. In this review, we summarize the burden of psoriatic disease, discuss the challenges in the care of psoriaticpatients, and outline how combined dermatology-rheumatology clinics bridge many of these gaps. RECENT FINDINGS: Multiple challenges are faced in providing high-quality care to patients with psoriasis and psoriatic arthritis from the pre-diagnosis phase of disease to the follow-up period. Challenges are mainly driven by lack of education of patients and healthcare providers, inefficient communication between specialists, lack of a holistic approach to patients, and limitations of available therapies. The Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) is working on demonstrating the effectiveness of combined dermatology-rheumatology clinics in addressing some of these challenges. Recent findings show that combined clinic models may improve quality of care by raising awareness of psoriatic disease, fostering educational activities for both patients and physicians, and allowing for comprehensive evaluation and management of patients through improved communications between disciplines. Psoriasis and psoriatic arthritis are complex diseases that often require an interdisciplinary approach. Thus, combined dermatology-rheumatology clinics and local-regional partnerships are potentially effective in improving quality of care in psoriatic disease.
Entities:
Keywords:
Interdisciplinary communication; Psoriasis; Psoriatic arthritis; Quality of healthcare
Authors: Philip J Mease; Dafna D Gladman; Kim A Papp; Majed M Khraishi; Diamant Thaçi; Frank Behrens; Robert Northington; Joanne Fuiman; Eustratios Bananis; Robert Boggs; Daniel Alvarez Journal: J Am Acad Dermatol Date: 2013-08-24 Impact factor: 11.527
Authors: Axel Patrice Villani; Marie Rouzaud; Morgane Sevrain; Thomas Barnetche; Carle Paul; Marie-Aleth Richard; Marie Beylot-Barry; Laurent Misery; Pascal Joly; Michel Le Maitre; Selim Aractingi; François Aubin; Alain Cantagrel; Jean-Paul Ortonne; Denis Jullien Journal: J Am Acad Dermatol Date: 2015-06-06 Impact factor: 11.527
Authors: Guillaume Favier; Dafna D Gladman; Joseph F Merola; April W Armstrong; Wolf Henning Boehncke; Philip S Helliwell Journal: J Rheumatol Date: 2017-05 Impact factor: 4.666
Authors: Alexis Ogdie; W Benjamin Nowell; Eddie Applegate; Kelly Gavigan; Shilpa Venkatachalam; Marie de la Cruz; Emuella Flood; Ethan J Schwartz; Beverly Romero; Peter Hur Journal: BMC Rheumatol Date: 2020-01-10
Authors: Kasper Fjellhaugen Hjuler; Anders Dige; Jørgen Agnholt; Trine Bay Laurberg; Anne Gitte Loft; Louise Faurskov Møller; Robin Christensen; Lars Iversen Journal: BMJ Open Date: 2021-04-28 Impact factor: 2.692
Authors: Lourdes M Perez-Chada; Rebecca H Haberman; Joseph F Merola; Jose U Scher; Vinod Chandran; Cheryl F Rosen; Christopher Ritchlin; Lihi Eder; Philip Mease; Soumya Reddy; Alexis Ogdie Journal: Nat Rev Rheumatol Date: 2021-02-15 Impact factor: 20.543
Authors: Nienke J Kleinrensink; Frank T Perton; Juliëtte N Pouw; Nanette L A Vincken; Sarita A Y Hartgring; Mylène P Jansen; Saeed Arbabi; Wouter Foppen; Pim A de Jong; Janneke Tekstra; Emmerik F A Leijten; Julia Spierings; Floris P J G Lafeber; Paco M J Welsing; Marloes W Heijstek Journal: BMJ Open Date: 2022-10-10 Impact factor: 3.006